Epidemiological Transitions in Influenza Dynamics in the United States: Insights from Recent Pandemic Challenges
Microorganisms,
Journal Year:
2025,
Volume and Issue:
13(3), P. 469 - 469
Published: Feb. 20, 2025
The
SARS-CoV-2
pandemic
has
reshaped
the
epidemiological
landscape
of
respiratory
diseases,
with
profound
implications
for
seasonal
influenza.
Nonpharmaceutical
interventions
implemented
globally
during
significantly
altered
human
behavior
and
reduced
prevalence
pathogens,
including
However,
post-pandemic
resurgence
influenza
activity
to
pre-pandemic
levels
highlights
persistent
challenges
posed
by
this
virus.
During
2023–2024
season
in
United
States,
an
estimated
40
million
individuals
contracted
influenza,
resulting
470,000
hospitalizations
28,000
deaths,
elderly
disproportionately
affected.
Pediatric
mortality
was
also
notable,
724
deaths
reported
among
children.
This
study
examines
trends
incidence,
vaccination
rates,
States
from
2018–2019
through
seasons.
Additionally,
it
evaluates
interplay
between
pandemic,
considering
impact
disrupted
air
travel,
public
health
measures,
virus
circulation
dynamics.
By
integrating
these
insights,
underscores
critical
need
sustained
campaigns
innovative
strategies
mitigate
dual
burden
diseases.
Findings
analysis
highlight
urgency
strengthening
prevention
surveillance
systems
enhance
preparedness
reduce
pathogens
evolving
landscape.
Language: Английский
The Impact of the COVID-19 Pandemic on the Clinical and Epidemiological Profile of Severe Acute Respiratory Infection in Bahia, Brazil: A Comparative Analysis of Pre- and Post-Pandemic Trends
Viruses,
Journal Year:
2025,
Volume and Issue:
17(3), P. 389 - 389
Published: March 9, 2025
In
recent
years,
the
incidence
of
Severe
Acute
Respiratory
Infection
(SARI)
has
increased
due
to
emergence
SARS-CoV-2.
However,
impact
COVID-19
pandemic
extends
beyond
mortality
rates.
Recent
analyses
suggest
that
introduction
and
spread
SARS-CoV-2
have
significantly
affected
epidemiology
other
key
respiratory
viruses,
such
as
influenza
virus
(FLUV),
syncytial
(RSV),
rhinovirus
(RV).
These
changes
raise
new
questions
about
dynamics
post-COVID-19
infections,
well
potential
alterations
in
symptom
profiles
clinical
outcomes.
this
study,
we
analyzed
data
from
Epidemiological
Surveillance
Information
System
Viral
Agents
(SIVEP-Gripe),
established
by
Brazilian
Ministry
Health,
examine
profile
SARI
before
during
Brazil.
Our
reveal
a
distinct
epidemiological
pattern,
with
significant
decrease
FLUV
notifications
pandemic,
accompanied
peaks
RSV
RV
cases
late
2020.
Additionally,
there
was
shift
age
distribution
viral
individuals
infected
being
older
than
those
pandemic.
Interestingly,
Bahia
State
resulted
reduction
frequency
symptoms
associated
non-SARS-CoV-2
SARI,
without
altering
findings
circulation
contributed
shift,
particularly
for
FLUV,
RSV,
marked
fever,
dyspnea,
distress,
need
ventilatory
support.
The
underlying
mechanisms
driving
these
remain
unclear.
insights
are
crucial
public
health
authorities
policymakers
refine
surveillance
strategies
enhance
control
measures
causing
SARI.
Language: Английский
Epidemiological characteristics of respiratory pathogens in Changchun, Jilin Province, China, following the pandemic
International Journal of Environmental Health Research,
Journal Year:
2025,
Volume and Issue:
unknown, P. 1 - 10
Published: April 2, 2025
This
study
investigates
the
changes
in
epidemiological
patterns
of
six
common
respiratory
pathogens
Changchun
City,
Jilin
Province,
following
pandemic.
Nucleic
acid
detection
using
a
quantitative
real-time
polymerase
chain
reaction
was
performed
on
collected
samples.
Results
showed
that
human
rhinovirus
(23.18%)
and
influenza
A
virus
(22.88%)
were
most
single-virus
infections.
The
combination
Mycoplasma
pneumoniae
adenovirus
accounted
for
18.57%
mixed
Gender
distribution
revealed
slightly
higher
rate
females
(49.81%)
than
males
(44.41%),
though
difference
not
statistically
significant.
Age-stratified
analysis
children
≤
14
years
had
highest
infection
rates
(22.22%).
Among
15-17-year-olds,
prevalent
(26.23%).
In
adults,
(22.47%)
(24.54%)
dominant
pathogens,
while
elderly
(≥60),
(36.54%)
syncytial
(25%)
leading
causes
infection.
Seasonal
indicated
autumn
winter
peak
seasons
infections,
with
pneumoniae,
virus,
returning
to
pre-pandemic
patterns.
Human
exhibited
year-round
circulation.
These
findings
offer
important
insights
into
shifting
epidemiology
post-pandemic.
Language: Английский
Seasonal Shifts in Influenza, Respiratory Syncytial Virus, and Other Respiratory Viruses After the COVID-19 Pandemic: An Eight-Year Retrospective Study in Jalisco, Mexico
Ernestina Quintero-Salgado,
No information about this author
Jaime Briseño-Ramírez,
No information about this author
Gabriel Vega‐Cornejo
No information about this author
et al.
Viruses,
Journal Year:
2024,
Volume and Issue:
16(12), P. 1892 - 1892
Published: Dec. 8, 2024
The
coronavirus
disease
2019
(COVID-19)
pandemic
profoundly
disrupted
the
epidemiology
of
respiratory
viruses,
driven
primarily
by
widespread
non-pharmaceutical
interventions
(NPIs)
such
as
social
distancing
and
masking.
This
eight-year
retrospective
study
examines
seasonal
patterns
incidence
influenza
virus,
syncytial
virus
(RSV),
other
viruses
across
pre-pandemic,
pandemic,
post-pandemic
phases
in
Jalisco,
Mexico.
Weekly
case
counts
were
analyzed
using
an
interrupted
time
series
(ITS)
model,
segmenting
timeline
into
these
three
distinct
phases.
Significant
reductions
circulation
observed
during
followed
atypical
resurgences
NPIs
relaxed.
Influenza
displayed
alternating
subtype
dominance,
with
A
H3
prevailing
2022,
B
surging
2023,
H1N1
increasing
thereafter,
reflecting
potential
immunity
gaps.
RSV
activity
was
marked
earlier
onset
higher
intensity
post-pandemic.
Other
including
human
rhinovirus/enterovirus
(HRV/HEV)
parainfluenza
(HPIV),
showed
altered
dynamics,
some
failing
to
return
pre-pandemic
seasonality.
These
findings
underscore
need
for
adaptive
surveillance
systems
vaccination
strategies
address
evolving
viral
patterns.
Future
research
should
investigate
long-term
public
health
implications,
focusing
on
vaccination,
clinical
outcomes,
healthcare
preparedness.
Language: Английский